Kimberly-Clark Corporation (KMB) continues to impress with its strong position as
high-yield dividend stocks for 2025 and beyond. Their potential for long-term passive income contribution further bolsters this. Recently, Russ Torres was promoted to
President and Chief Operating Officer (COO), indicating a progressive shift in the company's leadership. Experts suggest KMB's stock as one of the oversold global stocks to buy according to hedge funds. KMB's strategic vision will be discussed further in an upcoming
Goldman Sachs Forum. Reflecting on its Q1 2025 performance, the company announced strategic innovations and margin optimization amid cost pressures. The company is set to launch the largest U.S. investment in 30 years, pooling
$2 Billion to expand U.S manufacturing and spur innovation. KMB's intention to sell its $4B international tissue business was also noted. More positive news came as
Jim Cramer, a renowned stock picker, recommended KMB under Mike Hsu's leadership. Final words touch upon KMB's new investments, which include a $2B allocation to U.S manufacturing expansion, emphasizing its commitment towards domestic growth and innovation.
Kimberly-Clark Corp KMB News Analytics from Tue, 22 Oct 2024 07:00:00 GMT to Sat, 10 May 2025 09:43:53 GMT -
Rating 7
- Innovation 8
- Information 8
- Rumor -2
